Dubow Adam's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Aug 3, 2021
- Accession no.
- 0000014272-21-000196
- Filed
- Aug 3, 2021
- Trade date
- Jul 30, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $167.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dubow AdamCIK 0001744507 | Officer (SVP,ChiefCompliance&EthicsOff.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 30, 2021 | Common Stock, $0.10 par value | SSaleDisposed | −2,466 | $67.90 | −$167,441.4 | 13,777.15 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.